ArticleDiagnostic pathology2026
Sjögren's syndrome-focusassist: lymphocytic focus assessment in Sjögren's syndrome: a deep learning and spatial analysis approach.
Article in Diagnostic pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Sjögren’s syndrome (SS) is a chronic autoimmune disease whose clinical gold standard relies on precise quantification of lymphocyte foci and lymphocyte density in salivary gland biopsies. However, traditional manual assessment is time-consuming, highly subjective, and lacks consistency. To address these challenges, we propose Sjögren’s syndrome-FocusAssist (SS-FocusAssist), an end-to-end AI-assisted pathology framework for automated focus detection and quantification. At the cell-level detection stage, the system adopts an anchor-free single-stage detector enhanced with Coordinate Attention, improving the model’s ability to capture long-range spatial dependencies and identify minute lymphocytes. This design yields a precision of 95.9% and an mAP@0.5 of 99.1%, representing improvements of 11.1% and 7.3% over the baseline model. At the lesion-level aggregation stage, we introduce Filter-guided Adaptive Clustering (FAC): KDTree is first used to suppress spatial outliers, followed by DBSCAN with adaptive thresholds to form density-consistent lymphocytic foci; Finally, in the quantification stage, we develop an iterative expert-algorithm threshold optimization framework, guided by clinical diagnostic criteria, to achieve an optimal balance between lesion detection fidelity and pathological interpretability. In an independent cohort of 298 cases, SS-FocusAssist achieved a Cohen’s κ of 0.793 compared with dual-expert annotations—a 39% improvement over cell-detection-only methods. These results demonstrate that SS-FocusAssist substantially enhances the accuracy, consistency, and efficiency of SS biopsy interpretation, offering a clinically practical pathway for scalable digital pathology deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.